ENTITY

uniQure NV (QURE US)

16
Analysis
Health Care • Netherlands
uniQure N.V. delivers gene therapy with single treatments for curative results. The Company develops a modular platform to bring new disease modifying therapies to patients with severe genetic diseases, as well as offers ongoing clinical programs in hemophilia B and pre-clinical proof-of-concept in Huntington's disease.
more
Exchange Announcement • 29 Sep 2026 21:05

Current Report (Form 8-K | Period ending 2026-09-29)

Exchange Announcement • 02 Sep 2026 19:06

Current Report (Form 8-K | Period ending 2026-09-02)

Exchange Announcement • 29 Jul 2026 19:29

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 29 Jul 2026 19:17

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 29 Jul 2026 19:06

Current Report (Form 8-K | Period ending 2026-07-29)

x